Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Levonorgestrel
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Approved FDF
Sponsor : Aurobindo Pharma Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
New Healthcare Brand Launches Nationwide
Details : Julie emergency contraception offers Levonorgestrel 1.5mg, an FDA-approved, progestin-only emergency contraceptive that helps prevent pregnancy by temporarily delaying or stopping ovulation.
Product Name : Julie
Product Type : Hormone
Upfront Cash : Inapplicable
September 28, 2022
Lead Product(s) : Levonorgestrel
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved FDF
Sponsor : Aurobindo Pharma Limited
Deal Size : Inapplicable
Deal Type : Inapplicable